Working... Menu
Trial record 32 of 44 for:    somatostatin analogues | Neuroendocrine Tumors

Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02859064
Recruitment Status : Active, not recruiting
First Posted : August 8, 2016
Last Update Posted : May 30, 2019
Information provided by (Responsible Party):
SCRI Development Innovations, LLC

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : April 30, 2020
  Estimated Study Completion Date : May 31, 2020